ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 118 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,302 | -14.3% | 1,186 | -3.8% | 0.00% | – |
| Q2 2023 | $35,363 | +14.6% | 1,233 | -4.2% | 0.00% | – |
| Q1 2023 | $30,849 | +44.2% | 1,287 | +2.1% | 0.00% | – |
| Q4 2022 | $21,387 | +94.4% | 1,261 | +68.6% | 0.00% | – |
| Q3 2022 | $11,000 | -21.4% | 748 | -13.6% | 0.00% | – |
| Q2 2022 | $14,000 | -68.2% | 866 | -47.3% | 0.00% | – |
| Q1 2022 | $44,000 | -22.8% | 1,642 | +8.0% | 0.00% | – |
| Q4 2021 | $57,000 | -1.7% | 1,521 | +25.9% | 0.00% | – |
| Q3 2021 | $58,000 | -10.8% | 1,208 | -37.1% | 0.00% | – |
| Q2 2021 | $65,000 | -11.0% | 1,922 | +8.6% | 0.00% | – |
| Q1 2021 | $73,000 | +265.0% | 1,770 | +276.6% | 0.00% | – |
| Q4 2020 | $20,000 | -25.9% | 470 | -24.8% | 0.00% | – |
| Q3 2020 | $27,000 | -6.9% | 625 | 0.0% | 0.00% | – |
| Q2 2020 | $29,000 | +262.5% | 625 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | +14.3% | 625 | 0.0% | 0.00% | – |
| Q4 2019 | $7,000 | +16.7% | 625 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | 0.0% | 625 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | – | 625 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SEVEN EIGHT CAPITAL, LP | 46,819 | $2,031,000 | 0.47% |
| Orbimed Advisors | 1,206,886 | $49,844,000 | 0.47% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 25,000 | $1,033,000 | 0.40% |
| ARK Investment Management | 3,331,889 | $137,607,000 | 0.27% |
| FEDERATED HERMES, INC. | 3,203,000 | $132,284,000 | 0.26% |
| MGO ONE SEVEN LLC | 26,990 | $1,114,000 | 0.19% |
| Koss-Olinger Consulting, LLC | 20,000 | $826,000 | 0.14% |
| Jump Financial, LLC | 35,400 | $1,462,000 | 0.14% |
| Graham Capital Management, L.P. | 74,262 | $3,067,000 | 0.14% |
| New England Research & Management, Inc. | 6,005 | $248,000 | 0.14% |